United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver Failure [Yahoo! Finance]
United Therapeutics Corporation (UTHR)
Last united therapeutics corporation earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.unither.com/investor-relations
Company Research
Source: Yahoo! Finance
Approximately 30% of acute liver failure patients die because they are ineligible for a liver transplant or a donated liver is not available , demonstrating the critical need for organ alternatives SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., January 26, 2026 BUSINESS WIRE )--United Therapeutics Corporation (Nasdaq: UTHR ) today announced positive results from its phase 1 study of miroliver ELAP® , an external liver assist product, in patients with acute forms of liver failure, acute-on-chronic liver failure, and severe acute alcoholic hepatitis, collectively called acute liver failure ( ALF Developed by Miromatrix Medical Inc., a wholly owned subsidiary of United Therapeutics, miroliver ELAP consists of an external blood circuit and a single-use bioengineered liver sustained outside of the human body to provide temporary liver support to ALF patients. The bioengineered liver is manufactured by seeding a decellularized porcine liver scaffold with allogeneic human endothelia
Show less
Read more
Impact Snapshot
Event Time:
UTHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UTHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UTHR alerts
High impacting United Therapeutics Corporation news events
Weekly update
A roundup of the hottest topics
UTHR
News
- Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR) [Yahoo! Finance]Yahoo! Finance
- United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver FailureBusiness Wire
- United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of DirectorsBusiness Wire
- United Therapeutics Corporation (UTHR): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- JPM26: Jazz sells PRV for $200m, targets deals in 2026 [Yahoo! Finance]Yahoo! Finance
UTHR
Earnings
- 10/29/25 - Beat
UTHR
Sec Filings
- 1/28/26 - Form 4
- 1/28/26 - Form 4
- 1/23/26 - Form 4
- UTHR's page on the SEC website